About Concur Pharmaceuticals Private Limited
Data last updated:
Concur Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2011PTC215797. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Amrit Kaushal and Patanjali Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Office Space No F7&F8 1st Floor St.Soldier Tower Plot No. 3&4 Community Center G Block, Vikaspuri, Delhi, India – 110018.
As per the financials filed for FY 2024, the company reported a revenue of ₹9.98 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹31.15 Lakh (net margin 3.1%) and EBITDA of ₹49.84 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 3% over five years.
The company has about 61 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Concur Lives.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website concurlives.com.
Company details
Contact details
Concur Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is concurlives.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice Space No F7&F8 1st Floor St.Soldier Tower Plot No. 3&4 Community Center G Block, Vikaspuri, Delhi, India – 110018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Concur Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Concur Pharmaceuticals operates one associated brand: Concur Lives. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical solutions for chronic diseases in India and globally. | concurlives.com |
Business activity
The main business activity of Concur Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Concur Pharmaceuticals Private Limited, buy the company report.
Financials of Concur Pharmaceuticals Private Limited
FY 2024 filings availableConcur Pharmaceuticals Private Limited reported revenue of ₹9.98 Cr (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 17% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹49.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 3.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Concur Pharmaceuticals Private Limited, buy the company report.
Board of directors of Concur Pharmaceuticals Private Limited
Concur Pharmaceuticals has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrit Kaushal Also directs: Daikon Pharmaceuticals Private Limited | Director | 16 Jan 2012 | 14 Years 9 Months | Current |
| Patanjali Kumar Also directs: Reggel Lifesciences Private Limited | Director | 16 Jan 2012 | 14 Years 9 Months | Current |
| Ajeet Kumar | Director | 14 Mar 2011 | 15 Years 7 Months | Current |
| Sandip Hazari Also directs: Alegria Labs Private Limited, Shatnirvana Life Care Foundation | Director | 05 Mar 2012 | 14 Years 7 Months | Current |
| Ravi Shankar Choudhary | Director | 05 Mar 2012 | 14 Years 7 Months | Current |
Peer comparison
Concur Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Try Bird Healthcare Private Limited | ₹10 Cr (FY 2024) | 6.0% | Chandigarh, India | |||
| Civanta Distributors Private Limited | ₹10 Cr (FY 2024) | 3355.0% | Ahmedabad, Gujarat, India | |||
| N B Marketing Private Limited | ₹9.98 Cr (FY 2025) | Delhi, India | ||||
| Concur Pharmaceuticals Private Limitedthis company | ₹9.98 Cr (FY 2024) | ₹31.15 Lakh | 3.1% | 17.0% | 61 | Delhi, India |
| Akognos Life Sciences Private Limited | ₹9.97 Cr (FY 2025) | 5.0% | Delhi, India | |||
| Gupta Medico Agencies Private Limited | ₹9.95 Cr (FY 2024) | 17.0% | Mandi, Himachal Pradesh, India |
To see the full peer comparison of Concur Pharmaceuticals Private Limited, buy the company report.
Auditor
Concur Pharmaceuticals Private Limited is audited by Gupta Meenu & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gupta Meenu & Associates | FY 2023 | 534828 |
Shareholding
The shareholding of Concur Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Concur Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Concur Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Concur Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Concur Pharmaceuticals Private Limited has a workforce of 61 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
GST
Concur Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Concur Pharmaceuticals Private Limited, buy the company report.
Recent activity
Concur Pharmaceuticals Private Limited has 10 board changes on record since 2011: 5 appointments and 5 cessations. The latest: Amit Kumar Singh ceased to be Additional Director on 27 Mar 2018.
1 earlier event is in the company report.
Frequently asked questions
Concur Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 March 2011 (15+ years old) and is registered under CIN U24100DL2011PTC215797.
Concur Pharmaceuticals has 5 current directors:
- Amrit Kaushal - Director
- Patanjali Kumar - Director
- Ajeet Kumar - Director
- Sandip Hazari - Director
- Ravi Shankar Choudhary - Director
The latest financial statements of Concur Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Concur Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Concur Pharmaceuticals is U24100DL2011PTC215797. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Concur Pharmaceuticals was incorporated on 14 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Concur Pharmaceuticals by revenue are Try Bird Healthcare Private Limited, Civanta Distributors Private Limited, N B Marketing Private Limited, Akognos Life Sciences Private Limited, Gupta Medico Agencies Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Amit Kumar Singh ceased to be Additional Director on 27 Mar 2018. Amrit Kaushal ceased to be Managing Director on 27 Mar 2018. Ravi Rai ceased to be Additional Director on 27 Mar 2018. Concur Pharmaceuticals has 10 board changes on record in total.
Concur Pharmaceuticals can be reached through the website concurlives.com. Its registered office is in Delhi, India.
The registered office of Concur Pharmaceuticals is at Office Space No F7&F8 1st Floor St.Soldier Tower Plot No. 3&4 Community Center G Block, Vikaspuri, Delhi, India – 110018.
Concur Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.